Canada’s biotechnology sector is generating significant scientific and economic value, but the bigger question is where that value will ultimately be captured.

Дата публикации: 16-09-2026 14:41:55

In a new Hill Times op-ed, we look at what it will take to ensure more Canadian biotechnology companies can grow, commercialize and create lasting value here at home, while helping newRead More

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	BIONATION 2026 makes the case for Canadian biotech as a national priority	0	15.59	24-09-2026
2	Stem Cell Network – makes first direct biotech investment, awarding $1 million to Montreal-based RejuvenRx	0	21.55	22-09-2026
3	Accelerating Access to Cancer Medicines: Early Learnings from Ontario’s FAST Pilot	0	14.74	01-10-2026
4	Canada courts $1 trillion with mining at centre of pitch	0	10.46	14-09-2026
5	Biodextris – Appoints Clement Fourny as Chief Executive Officer	0	19.96	28-09-2026
6	Modulari-T Bioscience Announces a Research Collaboration with a Leading Global Biopharmaceutical Company for a Novel In Vivo CAR-T Program	0	17.25	30-09-2026
7	Sponsored video: AME urges tax fix to advance projects	0	7.69	02-09-2026
8	Corealis Pharma and PhinC Group – Collaborate to Bring Predictive Modeling into Early Formulation Development	0	12.39	16-09-2026
9	BRIEFING: Canada weathers regulatory spillover of US anti-ESG pressure, experts say	0	18.37	25-09-2026
10	Why provincial UK universities are enjoying tech spin-out success	0	10.95	16-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 15.31. Источник: www.biotech.ca.